An identity crisis for fps/fes: oncogene or tumor suppressor?

Abstract:

:Fps/Fes proteins were among the first members of the protein tyrosine kinase family to be characterized as dominant-acting oncoproteins. Addition of retroviral GAG sequences or other experimentally induced mutations activated the latent transforming potential of Fps/Fes. However, activating mutations in fps/fes had not been found in human tumors until recently, when mutational analysis of a panel of colorectal cancers identified four somatic mutations in sequences encoding the Fps/Fes kinase domain. Here, we report biochemical and theoretical structural analysis demonstrating that three of these mutations result in inactivation, not activation, of Fps/Fes, whereas the fourth mutation compromised in vivo activity. These results did not concur with a classic dominant-acting oncogenic role for fps/fes involving activating somatic mutations but instead raised the possibility that inactivating fps/fes mutations might promote tumor progression in vivo. Consistent with this, we observed that tumor onset in a mouse model of breast epithelial cancer occurred earlier in mice targeted with either null or kinase-inactivating fps/fes mutations. Furthermore, a fps/fes transgene restored normal tumor onset kinetics in targeted fps/fes null mice. These data suggest a novel and unexpected tumor suppressor role for Fps/Fes in epithelial cells.

journal_name

Cancer Res

journal_title

Cancer research

authors

Sangrar W,Zirgnibl RA,Gao Y,Muller WJ,Jia Z,Greer PA

doi

10.1158/0008-5472.CAN-04-3468

subject

Has Abstract

pub_date

2005-05-01 00:00:00

pages

3518-22

issue

9

eissn

0008-5472

issn

1538-7445

pii

65/9/3518

journal_volume

65

pub_type

杂志文章
  • Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.

    abstract::Intravesical mitomycin C (MMC) therapy is used to treat superficial bladder cancer. This study was to establish the intra- and intersubject variabilities in the systemic (plasma) and target site (bladder) exposure to the drug and to identify the factors which contribute to these variabilities. The pharmacokinetics of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dalton JT,Wientjes MG,Badalament RA,Drago JR,Au JL

    更新日期:1991-10-01 00:00:00

  • MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

    abstract::Activation of c-MYC is an oncogenic hallmark of many cancers, including liver cancer, and is associated with a variety of adverse prognostic characteristics. Despite a causative role during malignant transformation and progression in hepatocarcinogenesis, consequences of c-MYC activation for the biology of hepatic can...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0527

    authors: Akita H,Marquardt JU,Durkin ME,Kitade M,Seo D,Conner EA,Andersen JB,Factor VM,Thorgeirsson SS

    更新日期:2014-10-15 00:00:00

  • Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.

    abstract::Thyroid neoplasms show a wide variety of lesions varying from slowly growing differentiated adenocarcinomas to rapidly proliferating undifferentiated carcinomas. There has been some histopathological evidence that the undifferentiated thyroid carcinomas are derived from differentiated carcinomas. Moreover, it is suspe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ito T,Seyama T,Mizuno T,Tsuyama N,Hayashi T,Hayashi Y,Dohi K,Nakamura N,Akiyama M

    更新日期:1992-03-01 00:00:00

  • Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.

    abstract::Because of its relatively indolent clinical course, chronic lymphocytic leukemia (CLL) offers a versatile model for testing novel therapeutic regimens and drug combinations. Nicotinamide is the main NAD(+) precursor and a direct inhibitor of four classes of enzymes, including the sirtuins. SIRT1, the main member of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4452

    authors: Audrito V,Vaisitti T,Rossi D,Gottardi D,D'Arena G,Laurenti L,Gaidano G,Malavasi F,Deaglio S

    更新日期:2011-07-01 00:00:00

  • Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.

    abstract::We have previously identified amplification at 4q12 in testicular germ cell tumors of adolescents and adults centered around the KIT gene encoding a tyrosine kinase transmembrane receptor. Analysis of primary testicular germ cell tumors totaling 190 cases revealed 21% of the seminoma subtype with an increased copy num...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0471

    authors: McIntyre A,Summersgill B,Grygalewicz B,Gillis AJ,Stoop J,van Gurp RJ,Dennis N,Fisher C,Huddart R,Cooper C,Clark J,Oosterhuis JW,Looijenga LH,Shipley J

    更新日期:2005-09-15 00:00:00

  • Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin.

    abstract::Culturing DOV 13 ovarian carcinoma cells on three-dimensional collagen lattice but not on thin-layer collagen induces processing of promatrix metalloproteinase (MMP)-2 to a M(r) 62,000 form, suggesting that multivalent integrin aggregation may participate in proteinase regulation. To address the role of collagen-bindi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ellerbroek SM,Fishman DA,Kearns AS,Bafetti LM,Stack MS

    更新日期:1999-04-01 00:00:00

  • Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.

    abstract::We have carried out a clinical trial in which patients with relapsed leukemia were treated with thymidine (dThd) prior to and concomitantly with the administration of 1-beta-D-arabinofuranosylcytosine (ara-C) in an effort to kinetically and biochemically modulate the leukemic cells with two objectives: (a) to increase...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blumenreich MS,Chou TC,Andreeff M,Vale K,Clarkson BD,Young CW

    更新日期:1984-02-01 00:00:00

  • Patient-derived tumor xenografts: transforming clinical samples into mouse models.

    abstract::Tumor graft models (also known as patient-derived xenografts or PDX) are based on the transfer of primary tumors directly from the patient into an immunodeficient mouse. Because PDX mice are derived from human tumors, they offer a tool for developing anticancer therapies and personalized medicine for patients with can...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-13-1069

    authors: Siolas D,Hannon GJ

    更新日期:2013-09-01 00:00:00

  • Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions.

    abstract::The main objective of the present study was to sequentially analyze growth and morphological characteristics of aberrant crypt foci (ACF) in the rat colon. Sprague-Dawley rats were given a single injection of a carcinogenic dose of 1,2-dimethylhydrazine-HCl and at varying time points ranging from 2 to 57 weeks, groups...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McLellan EA,Medline A,Bird RP

    更新日期:1991-10-01 00:00:00

  • Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).

    abstract::CTLs were generated in vitro from two healthy donors and one melanoma patient by stimulation of CD8+ T cells with autologous dendritic cells pulsed with natural melanoma peptides (NMPs), obtained by acid treatment of HLA-matched melanoma cells. CTLs showed MHC class I-restricted melanoma-specific cytolytic activity. I...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Imro MA,Manici S,Russo V,Consogno G,Bellone M,Rugarli C,Traversari C,Protti MP

    更新日期:1999-05-15 00:00:00

  • Expression of Ca antigen in relation to cell cycle in cultured human tumor cells.

    abstract::In order to explain the heterogeneity of Ca antigen (Ca) expression observed previously on human malignant cells, a relationship of antigen content with events in the cell cycle was studied by multiparameter flow cytometry on four continuous human cell lines, HeLaS3, C4l, HT29, and T24, grown exponentially in culture....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Czerniak B,Darzynkiewicz Z,Staiano-Coico L,Herz F,Koss LG

    更新日期:1984-10-01 00:00:00

  • Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.

    abstract::We have screened 57 cases of primary, nonfunctional, pituitary adenomas for loss of heterozygosity of markers on chromosome 9p. Using a panel of 11 microsatellite markers, we found hemizygous deletion with at least one of the markers in 18 tumors (31.5%). The frequency of loss was similar in both noninvasive (8 of 26;...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Farrell WE,Simpson DJ,Bicknell JE,Talbot AJ,Bates AS,Clayton RN

    更新日期:1997-07-01 00:00:00

  • Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.

    abstract::Retroviral-mediated delivery of the P140K mutant O(6)-methylguanine-DNA methyltransferase (MGMT(P140K)) into hematopoietic stem cells (HSC) has been proposed as a means to protect against dose-limiting myelosuppressive toxicity ensuing from chemotherapy combining O(6)-alkylating agents (e.g., temozolomide) with pseudo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0320

    authors: Milsom MD,Jerabek-Willemsen M,Harris CE,Schambach A,Broun E,Bailey J,Jansen M,Schleimer D,Nattamai K,Wilhelm J,Watson A,Geiger H,Margison GP,Moritz T,Baum C,Thomale J,Williams DA

    更新日期:2008-08-01 00:00:00

  • Implementation of micromethods to resolve problems of human breast tumor heterogeneity in analysis of cyclic 3':5'-nucleotide phosphodiesterase.

    abstract::Individual human infiltrating ductal carcinomas and fibroadenomas were sectioned frozen to yield an alternating sequence of stained and lyophilized material. Stained preparations were used as references permitting microdissection of regions of tumor involvement in the corresponding dried sections. Tissues quantities o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Larner EH,Rutherford CL

    更新日期:1982-05-01 00:00:00

  • Involvement of disulfide bond formation in the activation of heparanase.

    abstract::Heparanase is overexpressed in many solid tumor cells and is capable of specifically cleaving heparan sulfate, and this activity is associated with the metastatic potential of tumor cells; however, the activation mechanism of heparanase has remained unknown. In this study, we investigated the link between disulfide bo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1053

    authors: Simizu S,Suzuki T,Muroi M,Lai NS,Takagi S,Dohmae N,Osada H

    更新日期:2007-08-15 00:00:00

  • Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.

    abstract::Hexosaminidase activity in prostatic tissue has been compared in 15 patients with benign prostatic hyperplasia and 15 patients with prostatic carcinoma. The ratio of enzymatic activity for the two substrates tested (p-nitrophenyl-2-acetamido-2-deoxy-beta-D-glucopyranoside and p-nitrophenyl-2-acetamido-2-deoxy-beta-D-g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Whitehurst GB,Mashburn JP,Pretlow TG 2nd,Bradley EL Jr,Boohaker EA

    更新日期:1982-10-01 00:00:00

  • Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ethionine in a choline-deficient diet.

    abstract::In this paper, we describe the production of a panel of monoclonal antibodies which define antigens which distinguish between hepatocytes and oval cells. These antibodies were obtained from hybridomas constructed from the spleens of mice immunized by a novel protocol designed to suppress response to unwanted or immuno...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hixson DC,Allison JP

    更新日期:1985-08-01 00:00:00

  • Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.

    abstract::Activities of the adenine purine nucleotide cycle enzymes, i.e., adenylosuccinate (SAMP) synthetase, SAMP lyase, and adenosine 5'-monophosphate deaminse, were determined in hepatic tissue of rats fed and/or given injections of 3'-methyl-4-dimethylaminoazobenzene, 4'-methyl-4-dimethylaminoazobenzene, thioacetamide, eth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smith LD,Emerson RL,Nixon LK

    更新日期:1979-06-01 00:00:00

  • Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus.

    abstract::Neonatal and adult BALB/c mice were investigated in a longitudinal study for the acquisition of leukemia-associated inhibitory activity (LIA) interactions after inoculation with Abelson virus in vivo. Within 2 to 4 days after virus infection, the granulocyte-macrophage colony-forming cells from the bone marrow and spl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE,Ralph P,Gilbertson S,Margolis VB

    更新日期:1980-11-01 00:00:00

  • Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

    abstract::Cyclooxygenase-2 (Cox-2) expression can induce mammary tumorigenesis in transgenic mice, and selective Cox-2 inhibitors are both chemopreventive and chemotherapeutic in rat models of breast cancer. We analyzed the expression of Cox-2 protein by immunohistochemistry in tissue array specimens of 1576 invasive breast can...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ristimäki A,Sivula A,Lundin J,Lundin M,Salminen T,Haglund C,Joensuu H,Isola J

    更新日期:2002-02-01 00:00:00

  • Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity.

    abstract::Salvage of preformed nucleosides requires transport across the plasma membrane by sodium-dependent (concentrative) and sodium-independent (equilibrative) mechanisms. These transport systems are also the route of cellular uptake for nucleoside analogues, including gemcitabine (2',2'-difluorodeoxycytidine), a deoxycytid...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rauchwerger DR,Firby PS,Hedley DW,Moore MJ

    更新日期:2000-11-01 00:00:00

  • Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

    abstract::After 10 years of clinical trials in patients with advanced cancer, monoclonal antibodies (mAbs) against cell surface antigens have not lived up to their initial promise. One such cell surface antigen is the ganglioside GD2. GD2 is richly expressed at the cell surfaces of human neuroblastomas, sarcomas, and melanomas....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang H,Zhang S,Cheung NK,Ragupathi G,Livingston PO

    更新日期:1998-07-01 00:00:00

  • Treatment of Dunning R3327-AT rat prostate tumors with photodynamic therapy in combination with misonidazole.

    abstract::Fischer X Copenhagen rats bearing Dunning R3327-AT tumors were treated with hematoporphyrin derivative and red light (630 nm from an argon-driven dye laser) alone or in combination with the hypoxic cell radiosensitizer, misonidazole (MISO). In vitro studies had suggested that hypoxia might significantly decrease the c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gonzalez S,Arnfield MR,Meeker BE,Tulip J,Lakey WH,Chapman JD,McPhee MS

    更新日期:1986-06-01 00:00:00

  • Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model.

    abstract::Successful systemic gene therapy has been hindered by vector-related limitations, including toxicity and inefficient gene delivery to tumor cells after i.v. administration. To circumvent these problems, we developed a novel formulation between the polycation polyethyleneimine and DNA that mediates high-level tumor cel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sweeney P,Karashima T,Ishikura H,Wiehle S,Yamashita M,Benedict WF,Cristiano RJ,Dinney CP

    更新日期:2003-07-15 00:00:00

  • An early event associated with liver carcinogenesis involving loss of a polypeptide that binds carcinogen.

    abstract::This report describes an early and direct action of oncogenic agents and its apparent consequences. Chemical carcinogen has been found to interact principally with a specific polypeptide in livers of normal rats. Short-term ingestion of carcinogen causes marked reductions in the concentrations of both the carcinogen:p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blackburn GR,Andrews JP,Rao KV,Sorof S

    更新日期:1980-12-01 00:00:00

  • Identification of an enhancer responsible for tumor marker gene expression by means of transgenic rats.

    abstract::The glutathione transferase P (GST-P) gene is known for its specific expression during chemical hepatocarcinogenesis of the rat and is used as a tumor marker for hepatocellular carcinoma. We have shown recently that the upstream 2.9-kb region of the GST-P gene is sufficient for conferring tumor-specific expression of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Suzuki T,Imagawa M,Hirabayashi M,Yuki A,Hisatake K,Nomura K,Kitagawa T,Muramatsu M

    更新日期:1995-06-15 00:00:00

  • Copper, zinc, and iron in normal and leukemic lymphocytes from children.

    abstract::Copper, zinc, and iron were quantitated in the serum and lymphoid cells of the peripheral blood of healthy children and children with acute lymphocytic leukemia. Copper and iron concentrations in serum and cells were significantly higher and zinc concentration in the cells significantly lower in leukemic patients than...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Carpentieri U,Myers J,Thorpe L,Daeschner CW 3rd,Haggard ME

    更新日期:1986-02-01 00:00:00

  • Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.

    abstract::The mechanisms which control estrogen receptor (ER) expression in breast carcinoma have not been elucidated. The MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) breast carcinoma cell lines have been used to examine ER gene expression. Northern blot analysis of mRNA isolated from these two cell lines demonstrates that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weigel RJ,deConinck EC

    更新日期:1993-08-01 00:00:00

  • Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine.

    abstract::Mammalian DNA polymerase beta is a DNA repair enzyme expressed constitutively at a low level. In vitro, purified DNA polymerase (Pol) beta incorporates the nucleotide analogues 2'-3' deoxycytidine (ddC)-triphosphate and 3'-azido-3'-deoxythymidine (AZT)-triphosphate into DNA, causing chain termination. We have tested t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bouayadi K,Hoffmann JS,Fons P,Tiraby M,Reynes JP,Cazaux C

    更新日期:1997-01-01 00:00:00

  • Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice.

    abstract::As recently characterized, following s.c. implantation into syngeneic C57BL/6 mice, E0771 tumor invades locally into dermal layers and peritoneum, metastasizes to the lung, and induces a nonspecific immunosuppression in the host. Using this breast medullar adenocarcinoma model, a therapy consisting of a single moderat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3963

    authors: Ewens A,Luo L,Berleth E,Alderfer J,Wollman R,Hafeez BB,Kanter P,Mihich E,Ehrke MJ

    更新日期:2006-05-15 00:00:00